Collaborators NOVEMBER 2022 EpiAxis enters agreement with Seattle Children’s Research Institute SEPTEMBER 2022 EpiAxis enters strategic partnership with UHN AUGUST 2022 EpiAxis & Peptilogics enter strategic drug discovery partnership DECEMBER 2021 EpiAxis expands its PKC theta pre-clinical program with Mount Sinai